External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit?

ConclusionOur study confirms the effect of DPF is highly dependent on several clinical –pathological variables, with discreet and gradually declining benefit over platinum doublets in later years, at the expense of increased toxicity. These results may help to underpin the idea that external validity of AGC trials should be revised regularly.
Source: Gastric Cancer - Category: Gastroenterology Source Type: research